{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:17:51Z","timestamp":1763018271835,"version":"3.37.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T00:00:00Z","timestamp":1605225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T00:00:00Z","timestamp":1605225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s10096-020-04096-z","type":"journal-article","created":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T05:02:57Z","timestamp":1605243777000},"page":"941-948","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Characteristics of gram-negative bacteremia during febrile neutropenia among allogeneic hematopoietic stem cell transplant recipients on levofloxacin prophylaxis"],"prefix":"10.1007","volume":"40","author":[{"given":"Sho","family":"Ogura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4461-1500","authenticated-orcid":false,"given":"Muneyoshi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinsuke","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Mitsuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiro","family":"Yuasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosei","family":"Kageyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Kaji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Taya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Ishiwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisashi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Asano-Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Go","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoyuki","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Wake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichi","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Araoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,13]]},"reference":[{"issue":"Suppl 1","key":"4096_CR1","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.1016\/j.ijantimicag.2007.06.012","volume":"30","author":"J Klastersky","year":"2007","unstructured":"Klastersky J, Ameye L, Maertens J, Georgala F, Muanza F, Aoun M et al (2007) Bacteraemia in febrile neutropenic cancer patients. Int J Antimicrob Agents 30(Suppl 1):S51\u2013S59","journal-title":"Int J Antimicrob Agents"},{"key":"4096_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1399-3062.2005.00088.x","volume":"7","author":"NG Almyroudis","year":"2005","unstructured":"Almyroudis NG, Fuller A, Jakubowski A, Sepkowitz K, Jaffe D, Small TN et al (2005) Pre- and post-engraftment bloodstream infection rates and associated mortality in allogeneic hematopoietic stem cell transplant recipients. Transpl Infect Dis 7:11\u201317","journal-title":"Transpl Infect Dis"},{"key":"4096_CR3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/sj.bmt.1705690","volume":"40","author":"DD Poutsiaka","year":"2007","unstructured":"Poutsiaka DD, Price LL, Ucuzian A, Chan GW, Miller KB, Snydman DR (2007) Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortality. Bone Marrow Transplant 40:63\u201370","journal-title":"Bone Marrow Transplant"},{"key":"4096_CR4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.bbmt.2008.10.024","volume":"15","author":"M Mikulska","year":"2009","unstructured":"Mikulska M, Del Bono V, Raiola AM, Bruno B, Gualandi F, Occhini D et al (2009) Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of gram-negative rods and increasing antibiotic resistance. Biol Blood Marrow Transplant 15:47\u201353","journal-title":"Biol Blood Marrow Transplant"},{"key":"4096_CR5","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","volume":"15","author":"M Tomblyn","year":"2009","unstructured":"Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J (2009) Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 15:1143\u20131238","journal-title":"Biol Blood Marrow Transplant"},{"key":"4096_CR6","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1093\/cid\/ciq147","volume":"52","author":"AG Freifeld","year":"2011","unstructured":"Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious disease society of America. Clin Infect Dis 52:427\u2013431","journal-title":"Clin Infect Dis"},{"key":"4096_CR7","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ajic.2005.03.009","volume":"33","author":"ZA Kanafani","year":"2005","unstructured":"Kanafani ZA, Mehio-Sibai A, Araj GF, Kanaan M, Kanj SS (2005) Epidemiology and risk factors for extended-spectrum beta-lactamase-producing organisms: a case control study at a tertiary care center in Lebanon. Am J Infect Control 33:326\u2013332","journal-title":"Am J Infect Control"},{"key":"4096_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10096-004-1264-8","volume":"24","author":"G Mendelson","year":"2005","unstructured":"Mendelson G, Hait V, Ben-Israel J, Gronich D, Granot E, Raz R (2005) Prevalence and risk factors of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in an Israeli long-term care facility. Eur J Clin Microbiol Infect Dis 24:17\u201322","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"4096_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00277-011-1247-7","volume":"91","author":"CI Kang","year":"2012","unstructured":"Kang CI, Chung DR, Ko KS, Peck KR, Song JH, The Korean Network for Study of Infectious Disease (KONSID) (2012) Risk factors for infection and treatment outcome of extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy. Ann Hematol 91:115\u2013121","journal-title":"Ann Hematol"},{"key":"4096_CR10","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.cmi.2017.03.024","volume":"23","author":"N Horita","year":"2017","unstructured":"Horita N, Shibata Y, Watanabe H, Namkoong H, Kaneko T (2017) Comparison of antipseudomonal \u03b2-lactams for febrile neutropenia empiric therapy: systematic review and network meta-analysis. Clin Microbial Infect 23:723\u2013729","journal-title":"Clin Microbial Infect"},{"key":"4096_CR11","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1086\/383054","volume":"39","author":"T Masaoka","year":"2004","unstructured":"Masaoka T (2004) Evidence-based recommendations for antimicrobial use in febrile neutropenia in Japan: executive summary. Clin Infect Dis 39:S49\u2013S52","journal-title":"Clin Infect Dis"},{"key":"4096_CR12","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1016\/j.bbmt.2014.06.024","volume":"20","author":"H Yamamoto","year":"2014","unstructured":"Yamamoto H, Uchida N, Matsuno N, Ota H, Kageyama K, Wada S et al (2014) Anti- HLA antibodies other than against HLA-A, B, DRB1 adversely affect engraftment and nonrelapse mortality in HLA-mismatched single cord blood transplantation: possible implications of unrecognized donor-specific antibodies. Biol Blood Marrow Transplant 20:1634\u20131640","journal-title":"Biol Blood Marrow Transplant"},{"key":"4096_CR13","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.bbmt.2008.12.497","volume":"15","author":"S Giral","year":"2009","unstructured":"Giral S, Ballen K, Rizzo D, Bacigalupo A, Horowitz M, Pasquini M, Sandmaier B (2009) Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research. Biol Blood Marrow Transplant 15:367\u2013369","journal-title":"Biol Blood Marrow Transplant"},{"key":"4096_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0924-8579(98)00060-0","volume":"11","author":"JW Chow","year":"1999","unstructured":"Chow JW, Yu VL (1999) Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary. Int J Antimicrob Agents 11:7\u201312","journal-title":"Int J Antimicrob Agents"},{"key":"4096_CR15","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s10096-014-2305-6","volume":"34","author":"C Nourrisson","year":"2015","unstructured":"Nourrisson C, Tan RN, Hennequin C, Gibold L, Bonnet R, Robin F (2015) The MAST\u00ae D68C test: an interesting tool for detecting extended-spectrum \u03b2-lactamase (ESBL)-producing Enterobacteriaceae. Eur J Clin Microbiol Infect Dis 34:975\u2013983","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"4096_CR16","unstructured":"Clinical and Laboratory Standard Institute (2019) Performance standards for antimicrobial susceptibility testing, 29th Edition: CLSI M100-ED29"},{"key":"4096_CR17","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y (2013) Investigation of the freely available east-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant 48:452\u2013458","journal-title":"Bone Marrow Transplant"},{"key":"4096_CR18","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/tid.12175","volume":"16","author":"O Blennow","year":"2014","unstructured":"Blennow O, Ljungman P, Sparrelid E, Mattsson J, Remberger M (2014) Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations. Transpl Infect Dis 16:106\u2013114","journal-title":"Transpl Infect Dis"},{"key":"4096_CR19","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1093\/cid\/cix690","volume":"65","author":"C Girmenia","year":"2017","unstructured":"Girmenia C, Bertaina A, Piciocchi A, Perruccio K, Algarotti A, Busca A et al (2017) Incidence, risk factors and outcome of pre-engraftment gram-negative bacteremia after allogeneic and autologous hematopoietic stem cell transplantation: an Italian prospective multicenter survey. Clin Infect Dis 65:1884\u20131896","journal-title":"Clin Infect Dis"},{"key":"4096_CR20","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1056\/NEJMoa044097","volume":"353","author":"G Bucaneve","year":"2005","unstructured":"Bucaneve G, Micozzi A, Menichetti F, Martino P, Dionisi MS, Martinelli G et al (2005) Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. N Engl J Med 353:977\u2013987","journal-title":"N Engl J Med"},{"key":"4096_CR21","doi-asserted-by":"publisher","first-page":"979","DOI":"10.7326\/0003-4819-142-12_Part_1-200506210-00008","volume":"142","author":"A Gafter-Gvili","year":"2005","unstructured":"Gafter-Gvili A, Fraser A, Paul M, Leibovici L (2005) Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients. Ann Intern Med 142:979\u2013995","journal-title":"Ann Intern Med"},{"key":"4096_CR22","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.cmi.2014.11.022","volume":"21","author":"EM Trecarichi","year":"2015","unstructured":"Trecarichi EM, Pagano L, Candoni A, Pastore D, Cattaneo C, Fanci R et al (2015) Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey. Clin Microbiol Infect 21:337\u2013343","journal-title":"Clin Microbiol Infect"},{"key":"4096_CR23","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1086\/655131","volume":"51","author":"PW Kim","year":"2010","unstructured":"Kim PW, Wu Y, Cooper C, Rochester G, Valappil T, Wang Y et al (2010) Meta-analysis of a possible signal of increased mortality associated with cefepime use. Clin Infect Dis 51:381\u2013389","journal-title":"Clin Infect Dis"},{"key":"4096_CR24","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/S1473-3099(07)70109-3","volume":"7","author":"D Yahav","year":"2007","unstructured":"Yahav D, Paul M, Fraser A, Sarid N, Leibovici L et al (2007) Efficacy and safety of cefepime: a systematic review and meta-analysis. Lancet Infect Dis 7:338\u2013348","journal-title":"Lancet Infect Dis"},{"key":"4096_CR25","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1093\/jac\/dkp411","volume":"65","author":"C Gudiol","year":"2010","unstructured":"Gudiol C, Calatayud L, Garcia-Vidal C, Lora-Tamayo J, Cisnal M, Duarte R et al (2010) Bacteraemia due to extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome. J Antimicrob Chemother 65:333\u2013341","journal-title":"J Antimicrob Chemother"},{"key":"4096_CR26","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1001\/jama.2008.896","volume":"300","author":"MJ Schwaber","year":"2008","unstructured":"Schwaber MJ, Carmeli Y (2008) Carbapenem-resistant Enterobacteriaceae: a potential threat. JAMA 300:2911\u20132913","journal-title":"JAMA"},{"key":"4096_CR27","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1001\/jama.2018.12163","volume":"320","author":"PNA Harris","year":"2018","unstructured":"Harris PNA, Tambyah PA, Lye DC, Mo Y, Lee TH, Yilmaz M et al (2018) Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with E coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance: a randomized clinical trial. JAMA 320:984\u2013994","journal-title":"JAMA"},{"key":"4096_CR28","first-page":"1720","volume":"67","author":"MJ Satlin","year":"2018","unstructured":"Satlin MJ, Chavda KD, Baker TM, Chen L, Shashkina E, Soave R et al (2018) Colonization with levofloxacin-resistant extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae and risk of bacteremia in hematopoietic stem cell transplant recipients. Clin Infect Dis 67:1720\u20131728","journal-title":"Clin Infect Dis"},{"key":"4096_CR29","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s10096-010-1093-x","volume":"30","author":"M Arnan","year":"2011","unstructured":"Arnan M, Gudiol C, Calatayud L, Li\u00f1ares J, Dominguez M\u00c1, Batlle M et al (2011) Risk factors for, and clinical relevance of, faecal extended-spectrum \u03b2-lactamase producing Escherichia coli (ESBL-EC) carriage in neutropenic patients with haematological malignancies. Eur J Clin Microbiol Infect Dis 30:355\u2013360","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"20","key":"4096_CR30","doi-asserted-by":"publisher","first-page":"30442\u20130","DOI":"10.1016\/j.bbmt.2020.07.011","volume":"S1083-8791","author":"JS Tanaka","year":"2020","unstructured":"Tanaka JS, Young RR, Heston SM, Jenkins K, Spees LP, Sung AD et al (2020) Anaerobic antibiotics and the risk of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant S1083-8791(20):30442\u20130. https:\/\/doi.org\/10.1016\/j.bbmt.2020.07.011","journal-title":"Biol Blood Marrow Transplant"},{"key":"4096_CR31","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1111\/1469-0691.12085","volume":"19","author":"MN Al-Hasan","year":"2013","unstructured":"Al-Hasan MN, Lahr BD, Eckel-Passow JE, Baddour LM (2013) Predictive scoring model of mortality in Gram-negative bloodstream infection. Clin Microbiol Infect 19:948\u2013954","journal-title":"Clin Microbiol Infect"},{"key":"4096_CR32","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s10096-005-1278-x","volume":"24","author":"WV Kern","year":"2005","unstructured":"Kern WV, Klose K, Jellen-Ritter AS, Oethinger M, Bohnert J, Kern P et al (2005) Fluoroquinolone resistance of Escherichia coli at a cancer center: epidemiologic evolution effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukemia. Eur J Clin microbial Infect Dis 24:111\u2013118","journal-title":"Eur J Clin microbial Infect Dis"},{"key":"4096_CR33","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1093\/cid\/ciy825","volume":"68","author":"M Hakki","year":"2019","unstructured":"Hakki M, Humphries RM, Hemarajata P, Tallman GB, Shields RK, Mettus RT et al (2019) Fluoroquinolone prophylaxis selects for meropenem-nonsusceptible Pseudomonas aeruginosa in patients with hematologic malignancies and hematopoietic cell transplant recipients. Clin Infect Dis 68:2045\u20132052","journal-title":"Clin Infect Dis"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-020-04096-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-020-04096-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-020-04096-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T11:16:15Z","timestamp":1619694975000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-020-04096-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,13]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["4096"],"URL":"https:\/\/doi.org\/10.1007\/s10096-020-04096-z","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"type":"print","value":"0934-9723"},{"type":"electronic","value":"1435-4373"}],"subject":[],"published":{"date-parts":[[2020,11,13]]},"assertion":[{"value":"23 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The protocol of this retrospective study was evaluated by the Human Ethics Review Committee of Toranomon Hospital and waived from the requirement of patient informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All the authors reviewed this study and agreed to publish this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"This study was approved by the Human Ethics Review Committee of Toranomon Hospital.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}